The Concept of Type-1 and Type-2 Helper T Cells and Their Cytokines in Humans
- 1 January 1998
- journal article
- research article
- Published by Taylor & Francis in International Reviews of Immunology
- Vol. 16 (3-4) , 427-455
- https://doi.org/10.3109/08830189809043004
Abstract
In both mice and humans, functionally distinct helper T (Th)-cell subsets, known as Th1 and Th2 cells, are characterized by the patterns of cytokines they produce. These two polarized forms of the specific cellular immune response provide a useful model for explaining not only the different types of protection, but also the pathogenic mechanisms of several immunopathological disorders. The development of polarized Th1 or Th2 responses depends on either environmental factors, including dose of antigen, nature of immunogen and cytokines (IL-12 and interferons or IL-4) at the time of antigen presentation, or other undefined factors in the individual genetic background, mainly at level of the so-called “natural immunity”. Th1-dominated responses are potentially effective in eradicating infectious agents, including those hidden within the host cells. When the Th1 response is poorly effective or exhaustively prolonged, it may result in host damage. In contrast, Th2 responses are apparently insufficient to protect against the majority of infectious agents, but can provide some protection against parasites. Th2 cells are able to make unpleasant the life of parasites in the host and tend to limit potentially harmful Th1-mediated responses. Thus, Th2 cells may be regarded as a part of down-regulatory (or suppressor) mechanism for exaggerated and/or inappropriate Th1 responses. The Th1/Th2 paradigm applied to the study of chronic inflammatory disorders or autoimmune diseases allowed to understand that a number of diseases are mediated by Th1 cells, the two clearest examples being multiple sclerosis and thyroid autoimmunity. In other disorders, Th1/Th2 polarization is less prominent, or rather Th2 responses tend to predominate, such as in systemic lupus erythematosus, progressive systemic sclerosis or allergic diseases. It is of note that in experimental models in animals, a number of diseases can be prevented by switching immune responses from Th1 to Th2 or from Th2 to Th1. Moreover, the Th1/Th2 concept suggests that modulation of the relative contribution of Th1-or Th2-type cytokines makes possible to regulate the balance between protection and immunopathology, as well as the development and/or the severity of some immunologic disorders.Keywords
This publication has 112 references indexed in Scilit:
- The contrasting roles of CD4+ T cells in intracellular infections in humans: leishmaniasis as an exampleImmunology Today, 1996
- Human naive CD4 T cells produce interleukin‐4 at priming and acquire a Th2 phenotype upon repetitive stimulations in neutral conditionsEuropean Journal of Immunology, 1995
- Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cellsImmunology Today, 1994
- Relationship of lnterleukin-4 to Isotypic Distribution of Anti-Double-Stranded DNA Antibodies in Systemic Lupus erythematosusInternational Archives of Allergy and Immunology, 1993
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- Regulation and biological function of helminth-induced cytokine responsesImmunology Today, 1991
- TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunityImmunology Today, 1991
- Fibrogenic cytokines: the role of immune mediators in the development of scar tissueImmunology Today, 1991
- Immunohistochemical analysis of intrathyroidal lymphocytes in Graves' disease: Evidence of activated T cells and production of interferon-γClinical Immunology and Immunopathology, 1988
- Recent Developments in Nonspecific Inflammatory Bowel DiseaseNew England Journal of Medicine, 1982